financetom
Business
financetom
/
Business
/
Odysight.ai Files $200 Million Mixed Shelf
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Odysight.ai Files $200 Million Mixed Shelf
Mar 11, 2026 2:24 AM

04:35 PM EST, 01/30/2026 (MT Newswires) -- Odysight.ai ( ODYS ) late Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to $200 million of securities from time to time.

The filing covers common stock, subscription rights, debt securities, warrants, and units.

The company plans to use the proceeds for research and development, sales and marketing, working capital and other general corporate purposes, the filing showed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RedHill Biopharma Says US Issues New Coronavirus Patent for Opaganib
RedHill Biopharma Says US Issues New Coronavirus Patent for Opaganib
Oct 2, 2024
08:34 AM EDT, 09/30/2024 (MT Newswires) -- RedHill Biopharma ( RDHL ) said Monday that the US has issued a new patent for identifying a novel biomarker of coronavirus pneumonia prognostic for potential opaganib efficacy for the treatment of COVID-19. The patent from the US Patent and Trademark Office would be granted on Oct. 15 and be valid through 2041,...
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
Oct 2, 2024
On Monday, Prime Medicine Inc. ( PRME ) announced a strategic research collaboration and license agreement with Bristol Myers Squibb & Co ( BMY )  to develop reagents for the next generation of ex vivo T-cell therapies. Under the terms of the agreement, Prime Medicine ( PRME ) will design optimized Prime Editor reagents for a select number of targets, including reagents...
Mobix Labs Proposes All-Cash Offer for Emcore
Mobix Labs Proposes All-Cash Offer for Emcore
Oct 2, 2024
08:36 AM EDT, 09/30/2024 (MT Newswires) -- Mobix Labs ( MOBX ) said Monday it has submitted a non-binding cash offer to acquire Emcore ( EMKR ) shares for $3.80 per share. The company said the acquisition represents a more than 200% premium over Emcore's ( EMKR ) Sept. 27 stock closing price. Mobix Labs' ( MOBX ) board of...
Murdoch's REA ends month-long takeover pursuit of Britain's Rightmove
Murdoch's REA ends month-long takeover pursuit of Britain's Rightmove
Oct 2, 2024
By Aby Jose Koilparambil (Reuters) -Rightmove's shares dropped 8% on Monday after Rupert Murdoch's REA Group ended its $8.29 billion takeover pursuit following a fourth bid rejection from the British real estate portal. Australian property listing firm REA's decision to walk away from making a formal offer for Rightmove ahead of a 1600 GMT deadline capped a month-long saga that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved